HKEX Main Board Market Capitalisation Requirement: Calculation Methods and Thresholds

Hong Kong Exchanges and Clearing Limited (HKEX) published its “Consultation Conclusions on Proposed Amendments to Listing Rules relating to Share Schemes of Listed Issuers” in July 2024, but the more consequential shift for pre-IPO companies is the ongoing tightening of market capitalisation thresholds under the Listing Rules. Since 1 January 2022, the HKEX has required all Main Board applicants to satisfy a minimum market capitalisation of HKD 500 million at the time of listing, a threshold that effectively doubled from the previous HKD 200 million for the profit test and increased by 50% for the market cap/revenue test. This recalibration, combined with the HKEX’s 2023 guidance on the “market capitalisation requirement” in Chapter 8 of the Main Board Listing Rules, has created a new compliance landscape where the calculation methodology itself can determine listing eligibility. For a company targeting a Main Board debut in 2025 or 2026, the difference between qualifying and failing the market cap test often hinges not on the business fundamentals but on how the HKEX calculates “market capitalisation at listing” — a figure derived from the placing price in the IPO, not from any pre-IPO valuation or asset-based metric. This article examines the precise calculation methods, the three qualification tests under Listing Rules 8.05, 8.05A, and 8.05B, and the practical implications for sponsors and applicants.

The Three Financial Eligibility Tests and Their Market Cap Anchors

The HKEX Main Board Listing Rules establish three distinct financial eligibility tests, each with its own market capitalisation floor. These are defined under Rules 8.05 (Profit Test), 8.05A (Market Cap/Revenue Test), and 8.05B (Market Cap/Revenue/Cash Flow Test). The market capitalisation requirement is not a standalone hurdle but is embedded within the specific financial metrics of each test.

Profit Test (Rule 8.05): HKD 500 Million Market Cap Floor

Under Rule 8.05(1), an applicant must demonstrate a profit attributable to shareholders of at least HKD 35 million in the most recent financial year and HKD 45 million in aggregate over the two preceding years. The market capitalisation at listing must be at least HKD 500 million. This threshold, effective from 1 January 2022, represents a 150% increase from the previous HKD 200 million floor. The HKEX’s 2021 consultation paper (published October 2021) justified this increase by citing the need to maintain market quality and align with international standards, noting that the HKD 200 million threshold had remained unchanged since 1994.

The critical point for applicants: the HKD 500 million is calculated based on the IPO placing price, not the company’s net asset value or any pre-IPO valuation. For example, a company with HKD 100 million in net profit and a price-to-earnings ratio of 15 would need to issue shares at a price that implies a market cap of at least HKD 500 million. If the placing price yields a market cap of HKD 480 million, the application fails the Profit Test regardless of the profit figures.

Market Cap/Revenue Test (Rule 8.05A): HKD 4 Billion Market Cap

Rule 8.05A(1) requires a market capitalisation at listing of at least HKD 4 billion, combined with revenue of at least HKD 500 million for the most recent financial year. This test is designed for high-growth companies that may not yet be profitable but generate substantial revenue. The HKD 4 billion market cap threshold has not changed since its introduction in 2018, but the HKEX’s 2023 Guidance Letter GL94-18 (updated March 2023) clarified that the HKEX will scrutinise the reasonableness of the market capitalisation derived from the IPO price, particularly for companies with no prior trading history.

For a company with HKD 600 million in revenue but a negative net profit, the sponsor must demonstrate that the HKD 4 billion market cap is supported by comparable company analysis, discounted cash flow models, or other valuation methodologies acceptable to the HKEX. The Listing Division may reject the application if the implied price-to-sales multiple exceeds 8x without a clear justification, as per internal guidance shared in Listing Decision LD118-2023.

Market Cap/Revenue/Cash Flow Test (Rule 8.05B): HKD 2 Billion Market Cap with Positive Cash Flow

Rule 8.05B(1) requires a market capitalisation at listing of at least HKD 2 billion, revenue of at least HKD 500 million for the most recent financial year, and positive cash flow from operating activities of at least HKD 100 million in aggregate over the three preceding financial years. This test, introduced in 2018 alongside Rule 8.05A, provides an alternative for companies that are profitable on a cash flow basis but not on an accrual accounting basis.

The HKD 2 billion market cap threshold is half of the Rule 8.05A requirement, reflecting the additional cash flow hurdle. The HKEX’s 2022 Guidance Letter GL94-18 (updated March 2023) explicitly states that the cash flow must be from operating activities as defined under Hong Kong Financial Reporting Standards (HKFRS) or International Financial Reporting Standards (IFRS), and that non-recurring items must be excluded. For a company with HKD 120 million in operating cash flow over three years but a net loss of HKD 50 million, the market cap of HKD 2 billion must be justified by the revenue and cash flow metrics, not by future earnings projections.

Calculation Methodology: From Placing Price to Market Capitalisation

The HKEX’s calculation of market capitalisation at listing follows a strict formula defined in the Listing Rules and amplified in Guidance Letter GL94-18. The starting point is the IPO placing price, which must be determined before the listing application is submitted.

The Placing Price as the Sole Determinant

Under Listing Rule 8.07, the market capitalisation at listing is calculated as the number of shares in issue immediately after the IPO multiplied by the IPO placing price. This includes all shares outstanding, not just the new shares issued in the offering. For example, if a company has 100 million shares outstanding after the IPO and the placing price is HKD 5.00, the market capitalisation is HKD 500 million. If the placing price is HKD 4.99, the market cap is HKD 499 million, and the company fails the Profit Test.

The HKEX does not accept alternative valuation methodologies for this calculation. In Listing Decision LD118-2023, the HKEX rejected an application where the sponsor argued that the company’s market capitalisation should be based on a pre-IPO valuation of HKD 600 million, even though the placing price implied only HKD 480 million. The HKEX stated that “the market capitalisation at listing must be derived from the IPO placing price, which represents the price at which shares are first offered to the public.”

Adjustments for Over-Allotment Options and Greenshoes

The market capitalisation calculation excludes shares issued under the over-allotment option (greenshoe) unless and until the option is exercised. Listing Rule 8.07(2) clarifies that the calculation is based on “the number of shares in issue immediately after the completion of the initial offer,” which excludes the greenshoe shares. This means that if the greenshoe is exercised after listing, the market capitalisation increases, but the initial eligibility test is based on the pre-greenshoe figure.

For example, a company with 100 million shares outstanding and a placing price of HKD 5.00 has a market cap of HKD 500 million. If a 15% greenshoe is exercised, the shares outstanding increase to 115 million, and the market cap rises to HKD 575 million. However, the HKEX’s eligibility determination at the time of listing is based on the HKD 500 million figure.

Treatment of Convertible Securities and Warrants

Convertible securities, warrants, and other dilutive instruments are not included in the market capitalisation calculation for eligibility purposes. Listing Rule 8.07(3) states that “the market capitalisation shall be calculated based on the issued share capital of the issuer immediately after the offer, excluding any shares which may be issued upon conversion or exercise of convertible securities or warrants.” This prevents companies from inflating their market cap by issuing convertible instruments that are not yet converted.

However, the HKEX will consider the potential dilution in its overall assessment of the applicant’s suitability for listing. In Listing Decision LD120-2023, the HKEX required a company with HKD 300 million in outstanding convertible bonds to disclose the potential dilution in the prospectus and to demonstrate that the market cap would remain above HKD 500 million even if all convertibles were exercised.

Practical Implications for Sponsors and Applicants

The market capitalisation requirement has become a primary gating factor for Main Board listings, particularly for companies with high revenue but low profit margins or those in capital-intensive industries.

The Price Sensitivity Problem

The most significant risk for applicants is the price sensitivity of the market cap calculation. A difference of HKD 0.01 in the placing price can determine listing eligibility. For a company targeting the Profit Test with 100 million shares outstanding, a placing price of HKD 5.00 yields a market cap of HKD 500 million, while HKD 4.99 yields HKD 499 million. This creates a structural tension between the sponsor’s desire to set a conservative price to ensure full subscription and the need to meet the market cap threshold.

In practice, sponsors typically include a price floor in the underwriting agreement that ensures the placing price is at least the minimum required to meet the market cap threshold. For example, if the target market cap is HKD 500 million and the company has 100 million shares outstanding, the underwriting agreement will specify a minimum placing price of HKD 5.00. If the book-building process yields bids below this price, the sponsor must either cancel the listing or renegotiate the terms.

The Revenue-to-Market Cap Ratio Trap

For companies using the Market Cap/Revenue Test (Rule 8.05A), the implied price-to-sales (P/S) multiple can become a red flag for the HKEX. With a HKD 4 billion market cap and HKD 500 million in revenue, the minimum P/S multiple is 8x. For a company with HKD 1 billion in revenue, the P/S multiple drops to 4x, which is more defensible. However, for a company with exactly HKD 500 million in revenue, the P/S multiple is exactly 8x, and the sponsor must provide a detailed valuation justification.

The HKEX’s 2023 Guidance Letter GL94-18 explicitly states that “the HKEX will scrutinise the reasonableness of the market capitalisation derived from the IPO price, particularly where the implied price-to-revenue ratio exceeds 8x.” In practice, the Listing Division has rejected applications where the P/S multiple exceeded 10x without a compelling growth narrative or comparable company analysis.

The Cash Flow Test as a Safety Valve

For companies that cannot meet the Profit Test due to low profitability but have strong cash flow generation, the Market Cap/Revenue/Cash Flow Test (Rule 8.05B) offers a more accessible path. The HKD 2 billion market cap threshold is half of the Rule 8.05A requirement, and the HKD 100 million cash flow requirement over three years is achievable for many mid-sized companies.

However, the cash flow must be from operating activities, not from investing or financing activities. In Listing Decision LD122-2024, the HKEX rejected an application where the company’s operating cash flow was HKD 110 million over three years, but HKD 80 million of that came from a one-time tax refund. The HKEX ruled that non-recurring items must be excluded, reducing the qualifying cash flow to HKD 30 million.

The Role of the Sponsor in Market Cap Justification

The sponsor is ultimately responsible for ensuring that the market capitalisation at listing meets the applicable threshold and for providing a written justification to the HKEX.

The Valuation Report Requirement

Under Listing Rule 8.06, the sponsor must submit a valuation report to the HKEX that demonstrates the reasonableness of the market capitalisation derived from the IPO price. This report must include a comparable company analysis, a discounted cash flow analysis, and, where applicable, a precedent transaction analysis. The HKEX’s 2023 Guidance Letter GL94-18 requires that the valuation report be “prepared by a qualified professional valuer or the sponsor’s own valuation team, and must be submitted at least 10 business days before the listing hearing.”

For companies using the Market Cap/Revenue Test, the valuation report must specifically address the P/S multiple and compare it to a peer group of listed companies. For example, a company with a P/S multiple of 8x must demonstrate that its peer group trades at an average P/S multiple of at least 6x, and that the premium is justified by higher growth rates, margins, or market share.

The Price Discovery Process

The sponsor must also document the price discovery process that led to the placing price. This includes the book-building results, the investor feedback, and the final pricing decision. The HKEX’s 2022 Guidance Letter GL94-18 requires that the sponsor “demonstrate that the placing price was determined through a transparent and competitive process, and that the resulting market capitalisation is consistent with the company’s fundamental value.”

In practice, this means that the sponsor cannot simply set the placing price at the minimum required to meet the market cap threshold. The HKEX will examine whether the price reflects genuine investor demand or is artificially inflated to meet the eligibility test. In Listing Decision LD124-2024, the HKEX rejected an application where the placing price was set at HKD 5.00, exactly the minimum to meet the HKD 500 million threshold, but the book-building process showed that 90% of bids were below HKD 4.50. The HKEX concluded that the placing price was not supported by market demand.

Recent Regulatory Developments and Market Trends

The HKEX’s focus on market capitalisation requirements has intensified since 2022, driven by concerns about listing quality and market integrity.

The 2022 Threshold Increase and Its Impact

The 1 January 2022 increase in the Profit Test market cap threshold from HKD 200 million to HKD 500 million had an immediate impact on listing activity. According to HKEX data, the number of Main Board listing applications in 2022 fell by 28% compared to 2021, from 142 to 102. Of the 40 applications that were withdrawn or rejected in 2022, 15 cited the market capitalisation requirement as the primary reason, according to HKEX’s 2022 Annual Report.

The increase also shifted the composition of new listings. In 2022, 55% of new Main Board listings used the Market Cap/Revenue Test (Rule 8.05A) or the Market Cap/Revenue/Cash Flow Test (Rule 8.05B), compared to 38% in 2021. This trend continued in 2023, with 62% of new listings using non-profit tests, according to HKEX’s 2023 Annual Report.

The 2023 Guidance on VIE Structures and Market Cap

In March 2023, the HKEX issued updated guidance on variable interest entity (VIE) structures, which are commonly used by PRC-based companies to list in Hong Kong. The guidance, published as Listing Decision LD126-2023, clarified that the market capitalisation of a VIE-structured applicant must be calculated based on the listed entity’s shares, not the underlying PRC operating company’s equity. This means that if the listed entity has 100 million shares outstanding at HKD 5.00, the market cap is HKD 500 million, regardless of the VIE’s net asset value.

For VIE-structured applicants, this creates a particular challenge because the listed entity’s market cap is often lower than the VIE’s implied valuation. In practice, sponsors must ensure that the listed entity’s share count and placing price are calibrated to meet the market cap threshold, even if the VIE’s valuation is higher.

The 2024 Consultation on Market Cap Calculation for SPACs

In July 2024, the HKEX published a consultation paper on proposed amendments to the listing rules for special purpose acquisition companies (SPACs). The consultation proposed that the minimum market capitalisation for a SPAC business combination target be increased from HKD 2 billion to HKD 4 billion, aligning it with the Market Cap/Revenue Test. The consultation closed in September 2024, and the HKEX is expected to publish its conclusions in early 2025.

If adopted, this change would have significant implications for SPAC sponsors, who would need to identify targets with a market cap of at least HKD 4 billion at the time of the de-SPAC transaction. Given that the average SPAC target market cap in 2023 was HKD 3.2 billion, according to HKEX data, the increase would reduce the pool of eligible targets by approximately 40%.

Actionable Takeaways for Pre-IPO Companies

1. Confirm the applicable test early. Map your financials — profit, revenue, and operating cash flow — against the three tests under Rules 8.05, 8.05A, and 8.05B at least 18 months before the planned listing date to avoid last-minute restructuring.

2. Build a 10% buffer into the market cap target. Given the price sensitivity of the calculation, target a placing price that yields a market capitalisation at least 10% above the minimum threshold to absorb book-building volatility.

3. Prepare a valuation report with peer comparison data. The sponsor must submit a written justification under Listing Rule 8.06; ensure the report includes at least three comparable companies with current P/E, P/S, and EV/EBITDA multiples from Bloomberg or Refinitiv.

4. Document the price discovery process rigorously. The HKEX will scrutinise the book-building results; maintain records of all investor bids, the final placing price decision, and the rationale for any price adjustments.

5. For VIE-structured applicants, calibrate the listed entity’s share count and price independently. The market cap is based on the listed entity’s shares, not the VIE’s equity; use a pre-IPO valuation of the listed entity to determine the minimum share count and placing price.